[pubmed] Therapeutic plasma exchange in neurological diseases: Eleven years experience a tertiary care center in Turkey

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6501
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    Mac OS X iPhone

[pubmed] Therapeutic plasma exchange in neurological diseases: Eleven years experience a tertiary care center in Turkey

Message par RSS-Bot »


Ther Apher Dial. 2021 Jun 26. doi: 10.1111/1744-9987.13703. Online ahead of print.

ABSTRACT

OBJECTIVE: Therapeutic plasma exchange (TPE) is an apheresis procedure in which plasma is separated from the blood cellular components ex vivo, allocated, and replaced with another plasma or a plasma-replacing fluid. This study aimed to define the rate of complications and determine TPE distribution in various neurological diseases.

MATERIALS AND METHODS: Our study is a retrospective analysis of neurologic diseases requiring TPE between 2008 and 2019 that were selected using the medical records of neurology departments and apheresis units database.

RESULTS: We performed 1459 TPE procedures on 207 patients between 2008 and 2019. TPE Procedure is most frequently applied in patients with Myasthenia-Gravis syndrome (34.7%). The complication ratio was 1.6% from a total of 1459 TPE procedures. The most commonly specified adverse event was allergic reactions 11 (5.3%), followed by hypotension 6 (2.9%).

CONCLUSION: TPE was safe and tolerable, with manageable complications in experienced hands. This article is protected by copyright. All rights reserved.

PMID:34173719 | DOI:10.1111/1744-9987.13703


Source: https://pubmed.ncbi.nlm.nih.gov/3417371 ... 1&v=2.14.4
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »